Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT00216866
Eligibility Criteria:
Inclusion Criteria:
* Males or females greater than or equal to 18 years of age, inclusive.
* Symptomatic acute upper limb thrombosis with or without pulmonary embolism associated with central venous catheter objectively documented by compression ultrasonography, venogram or computed tomography (CT) scan.
* Diagnosis of active malignancy, as defined by patients who are either receiving active treatment, or have metastatic disease or who have been diagnosed within the past two years.
* Willing to provide written informed consent.
Exclusion Criteria:
* Dialysis catheters.
* Active bleeding or high risk for major bleeding.
* Platelet count \< 100 x 10x9/L.
* Serum creatinine \> 177umol/L
* Currently on warfarin with therapeutic intent (does not include minidose warfarin used as prophylaxis for CV catheter thrombosis).
* Pulmonary embolism accompanied by hemodynamic instability or oxygen requirement.
* Inability to infuse through the catheter after a trial of intraluminal thrombolytic therapy.
* Patients with acute myelogenous leukemia (AML) or acute lymphoblastic leukemia (ALL) with a bone marrow or stem cell transplant pending in next 3 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00216866
Study Brief:
Protocol Section:
NCT00216866